Top compounds associated with response to APOD


Feature Type Standardized
Nominal ANOVA
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.037 0.3
mRNA TAE684 GDSC1000 pan-cancer AAC -0.062 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.038 0.3
mRNA MS-275 FIMM pan-cancer AAC 0.15 0.3
mRNA AT7867 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.043 0.3
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC -0.14 0.3
mRNA HG-5-113-01 GDSC1000 pan-cancer AAC -0.054 0.3
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC -0.078 0.3
Download CSV